276 related articles for article (PubMed ID: 7459879)
41. [Experimental model of urinary bladder tumor in rats for evaluation of chemotherapeutic agents].
Hirao Y; Momose H; Samma S; Ozono S; Babaya K; Okajima E
Hinyokika Kiyo; 1988 Nov; 34(11):1885-93. PubMed ID: 3242363
[TBL] [Abstract][Full Text] [Related]
42. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
43. Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression.
Herman CJ; Vegt PD; Debruyne FM; Vooijs GP; Ramaekers FC
Am J Pathol; 1985 Sep; 120(3):419-26. PubMed ID: 2412446
[TBL] [Abstract][Full Text] [Related]
44. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Moon RC
J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
[No Abstract] [Full Text] [Related]
45. Effect of simultaneous administration of leupeptin on induction of bladder tumors in rats by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Kakizoe T; Matsukura N; Aoyagi M; Kawachi T; Sugimura T
Gan; 1980 Feb; 71(1):138-40. PubMed ID: 7380132
[TBL] [Abstract][Full Text] [Related]
46. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
47. NTP Toxicology and Carcinogenesis Studies of C.I. Disperse Blue 1 (A commercial dye containing approximately 50% 1,4,5,8-tetraaminoanthraquinone, and 20% water) (CAS No. 2475-45-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1986 May; 299():1-241. PubMed ID: 12748707
[TBL] [Abstract][Full Text] [Related]
48. Lack of enhancing effect of mucosal regeneration following ulceration of the urinary bladder on N-butyl-N-(4-hydroxybutyl)nitrosamine carcinogenesis in rats.
Shirai T
Cancer Res; 1980 Oct; 40(10):3709-12. PubMed ID: 7438054
[TBL] [Abstract][Full Text] [Related]
49. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
[TBL] [Abstract][Full Text] [Related]
50. NTP Toxicology and Carcinogenesis Studies of Telone II(R) (Technical-Grade 1,3-Dichloropropene [CAS No. 542-75-6] Containing 1.0% Epichlorohydrin as a Stabilizer) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1985 May; 269():1-159. PubMed ID: 12748684
[TBL] [Abstract][Full Text] [Related]
51. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
Suzuki E; Anjo T; Aoki J; Okada M
Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
[TBL] [Abstract][Full Text] [Related]
52. Long-term effect of 2-hydroxyethyl retinamide on urinary bladder carcinogenesis and tumor transplantation in Fischer 344 rats.
Quander RV; Leary SL; Strandberg JD; Yarbrough BA; Squire RA
Cancer Res; 1985 Nov; 45(11 Pt 1):5235-9. PubMed ID: 4053003
[TBL] [Abstract][Full Text] [Related]
53. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
54. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB
Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158
[TBL] [Abstract][Full Text] [Related]
55. Interspecies analysis of the chemopreventive efficacy of dietary alpha-difluoromethylornithine.
Ratko TA; Detrisac CJ; Rao KV; Thomas CF; Kelloff GJ; Moon RC
Anticancer Res; 1990; 10(1):67-72. PubMed ID: 2110434
[TBL] [Abstract][Full Text] [Related]
56. Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine.
Fukushima S; Hirose M; Tsuda H; Shirai T; Hirao K
Gan; 1976 Feb; 67(1):81-90. PubMed ID: 1269859
[TBL] [Abstract][Full Text] [Related]
57. Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder.
Suzuki E; Aoki J; Okada M
Gan; 1981 Aug; 72(4):547-51. PubMed ID: 7308666
[TBL] [Abstract][Full Text] [Related]
58. A study of antitumor effects of thymosin on rat and mouse urinary bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Wada S; Kinoshita Y; Kamizuru M; Asai Y; Iwata H; Ikemoto S; Hato F; Kishimoto T; Fukushima S
Oncol Res; 1996; 8(3):139-44. PubMed ID: 8823810
[TBL] [Abstract][Full Text] [Related]
59. Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
Dunois-Lardé C; Levrel O; Brams A; Thiery JP; Radvanyi F
Mol Carcinog; 2005 Mar; 42(3):142-9. PubMed ID: 15690367
[TBL] [Abstract][Full Text] [Related]
60. The effects of sirolimus on urothelial lesions chemically induced in ICR mice by BBN.
Oliveira PA; Arantes-Rodrigues R; Sousa-Diniz C; Colaço A; Lourenço L; De La Cruz LF; Da Silva VM; Afonso J; Lopes C; Santos L
Anticancer Res; 2009 Aug; 29(8):3221-6. PubMed ID: 19661338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
